SCHEMBL8167132

SCHEMBL8167132

COC(=O)c1ccc(C#C/C=C/c2ccccc2-c2cccc(OC)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.44
NPC1 O15118 3/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.42
BLM P54132 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
ESR1 P03372 1/20 0.41
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
VDR P11473 1/20 0.41
RXRA P19793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7929254 0.91 SLC16A3 (0.44) RXRAPPARDVCPHDAC8HSP90AA1
SCHEMBL8175387 0.89 MAPT (0.40) RAB9ANPC1MAPTLMNAHTT
SCHEMBL8180309 0.88 HSD17B10 (0.40) RAB9ANPC1MAPTSMN1; SMN2POLB
SCHEMBL8167571 0.88 EGFR (0.41) ALDH1A1HPGDHSD17B10CA1CA2
SCHEMBL8175054 0.88 MAPT (0.44) RAB9ANPC1MAPTLMNAHTT
SCHEMBL8167359 0.88 CA1 (0.47) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL8175916 0.88 EGFR (0.46) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL8180652 0.88 MAPK14 (0.39) NPC1MAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL8180152 0.83 CA1 (0.46) LMNAALDH1A1HPGDHSD17B10CA1
SCHEMBL8167327 0.83 TDP1 (0.46) RAB9ANPC1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150413-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, BONE AND OPHTHALMOLOGICAL DISORDERS, AS WELL AS MAMMALIAN SKIN AND HAIR CONDITIONS; 4-(4-(BIPHENYL-2-YL)BUT-3-EN-1-YNYL)BENZOIC ACID, FOR EXAMPLE CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-11-21 US disclosed